Roivant Sciences Ltd.
US ˙ NasdaqGS ˙ BMG762791017

SecurityROIV / Roivant Sciences Ltd.
InstitutionNatixis Advisors, L.p.
Latest Disclosed Ownership95,776 shares
Latest Disclosed Value $ 2,653
Natixis Advisors, L.p. reports 50.64% increase in ownership of ROIV / Roivant Sciences Ltd.

On May 13, 2026 - Natixis Advisors, L.p. filed a 13F-HR form disclosing ownership of 95,776 shares of Roivant Sciences Ltd. (US:ROIV) valued at $2,652,995 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 63,581 shares of Roivant Sciences Ltd.. This represents a change in shares of 50.64% during the quarter. The current value of the position is $2,748,771 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ROIVANT SCIENCES LTD SHS COM G76279101 95,776 32,195 50.64 3 100.00 0.0037
2026-02-10 2025-12-31 13F ROIVANT SCIENCES LTD SHS COM G76279101 63,581 2,542 4.16 1 0.0020
2025-11-13 2025-09-30 13F ROIVANT SCIENCES LTD SHS COM G76279101 61,039 -8,496 -12.22 1 0.0013
2025-08-13 2025-06-30 13F ROIVANT SCIENCES LTD SHS COM G76279101 69,535 33,102 90.86 1 0.0012
2025-05-08 2025-03-31 13F ROIVANT SCIENCES COM G76279101 36,433 -15,187 -29.42 0 0.0007
2025-02-10 2024-12-31 13F ROIVANT SCIENCES LTD SHS COM G76279101 51,620 -102,097 -66.42 1 -100.00 0.0011
2024-11-06 2024-09-30 13F ROIVANT SCIENCES COM G76279101 153,717 11,726 8.26 2 0.00 0.0035
2024-08-01 2024-06-30 13F ROIVANT SCIENCES COM G76279101 141,991 15,280 12.06 2 0.00 0.0033
2024-04-25 2024-03-31 13F ROIVANT SCIENCES COM G76279101 126,711 64,352 103.20 1 0.0031
2024-02-06 2023-12-31 13F ROIVANT SCIENCES COM G76279101 62,359 62,359 1 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.